This could relate to different pharmacokinetic profiles, lower peak drug levels, or differences in how the oral versus injectable forms interact with the nervous system
Contact us for distributor guides or an RFQ
NAD+ energizes
Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance
Injection site selection matters for subcutaneous administration

Common infectious causes include: Upper respiratory tract infections colds, flu, COVID-19, or strep throat commonly cause cervical (neck) lymph node swelling Dental infections abscesses or gum disease can lead to submandibular or cervical lymphadenopathy Skin infections cellulitis, infected wounds, or insect bites may cause regional lymph node enlargement Viral infections Epstein-Barr virus (glandular fever), cytomegalovirus, or HIV can cause generalised lymphadenopathy Bacterial infections including tuberculosis, cat-scratch disease, or atypical mycobacterial infections Non-infectious causes to consider: Recent vaccinations COVID-19, influenza, or other vaccines can cause temporary lymph node swelling [5] Reactive nodes near injection sites local inflammation from any injection, including Mounjaro, may cause nearby lymph nodes to enlarge temporarily [6] Autoimmune conditions rheumatoid arthritis, systemic lupus erythematosus, or Sjgren's syndrome may present with lymph node swelling Medication reactions certain drugs (not typically including GLP-1 receptor agonists) can rarely cause lymphadenopathy Malignancy lymphoma, leukaemia, or metastatic cancer may present with persistent or progressive lymph node enlargement Sarcoidosis a multisystem inflammatory condition that can affect lymph nodes Coincidental timing: It is important to recognise that starting a new medication like Mounjaro may coincide with the development of an unrelated condition
